Biofields Therapy on Warts

Study Overview
=================
Brief Summary
-----------------
Traditionally, healers are willing to look after, two out of three French citizens have already appealed to them at least once during their lives. Many healers in good faith are exercising their magnetism as a gift often inherited from elders. Now, they create interest of doctors who do not hesitate in some cases to ensure their cooperation, to implicitly recognize their mysterious talents. Some serious studies have examined these practices: Several studies have been conducted on the influence of biofield therapies in pain, depression and fatigue in cancer disease. The investigators propose a study of the effect of magnetism on the wart disease whose cure is objectively assessable. Sixty-two subjects in total would be included, comparing 2 proportions observed: the proportion of healing in the group treated with a real biofield therapist (recognized and affiliated to the National Group for Alternative Medicine in France) to the proportion of healing in the group treated with a fake biofield therapist (someone assessed as not having capacity to magnetize). The fake biofield therapist, placebo, has been trained to replicate gestures during a training validated by an independent recognized biofield therapist.

Official Title
-----------------
Effect of the Intervention of Biofields Therapy on Warts of the Hands and Feet in Adults: a Prospective, Randomized, Double-blind Trial

Conditions
-----------------
Wart, Energy Medecine, Magnetism

Intervention / Treatment
-----------------
* Other: True Biofield therapy
* Other: Fake Biofield therapy


Participation Criteria
=================
Eligibility Criteria
-----------------
Patients with common warts on hands or feet for over at least 3 months are eligible for the study. Patients fulfilling one or more of the following criteria will not be included: lack of informed consent prior to randomization, younger than 18 years or under judicial protection, treated with oral corticotherapy for more than 6 months, immunosuppressed or with history of transplant surgery, undergoing chemotherapy or suspected to have carcinomatous warts, or patients with infected warts, injured warts or already treated within 90 days with chemical processing, medical device, surgery or ever treated with biofield therapy. Subject will be excluded from the study if its warts was treated by other treatment during protocol. ulcerated wart cancerous wart

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: True biofield therapist<br>Subject will have a 40 minutes therapy with a real biofield therapist to treat the wart | Other: True Biofield therapy<br> <br> |
| Placebo Comparator: Fake biofield therapist<br>Subject will have a 40 minutes therapy with a fake biofield therapist to treat the wart | Other: Fake Biofield therapy<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| disappearance of a common palmar or plantar wart |  | week 3 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| disappearance of each other wart than the original one 3 weeks after the therapy |  | week 3 | 
| Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3 |  | week3 | 
| Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3 |  | week 3 | 
| Disappearance of warts at 6 weeks |  | week 6 | 
| Level of belief in biofield therapy of the subject | week 0 | week 6 |